Biofil Chemicals and Pharmaceuticals Limited concluded its 41st Annual General Meeting on September 23, 2026, through Video Conference and Other Audio Visual Means. The meeting commenced at 3:03 pm and ended at 3:17 pm, with all agenda items transacted in compliance with SEBI and MCA circulars.

The company’s audited financial statements for the fiscal year ended March 31, 2026, were adopted by the shareholders. The statutory auditor’s report contained no qualifications or adverse remarks. Additionally, the secretarial auditor’s observations were noted as self-explanatory with no adverse effect on the company’s operations.

Director appointments and re-elections

Shareholders approved the re-appointment of Smitesh Shah as a director retiring by rotation under Section 152(6) of the Companies Act, 2013. A special resolution was passed to allow Ashok Kumar Ramawat to continue serving as a Non-Executive Independent Director despite attaining the age of 75 years.

Related party transactions

The meeting also addressed material related party transactions with Cyano Pharma Private Limited. An ordinary resolution was passed to approve these transactions, ensuring regulatory compliance with disclosure norms.

Meeting participation details

The AGM was conducted virtually due to prevailing guidelines, with the registered office in Indore deemed the venue. Remote e-voting facilities were provided from September 20 to September 22, 2026. Only one registered speaker raised queries during the session, which the management agreed to address via email.

The scrutinizer’s report and voting results will be submitted to the stock exchanges within the prescribed timeline under Regulation 44(3) of SEBI (LODR) Regulations, 2015.

Biofil Chemicals & Pharmaceuticals Limited announced its 41st Annual General Meeting (AGM) is scheduled for September 23, 2026, at 3:00 pm. The meeting will be conducted via Video Conferencing or Other Audio Visual Means (VC/OAVM). The notice was issued on August 26, 2026, pursuant to Regulation 30 read with Schedule III Part A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Agenda Items

The AGM will transact both ordinary and special business. Ordinary business includes the adoption of audited financial statements for FY26 and the re-appointment of Mr. Smitesh Shah as a Non-Executive Non-Independent Director. He retires by rotation under Section 152(6) of the Companies Act, 2013.

Special business includes two critical resolutions:

• Continuation of Independent Director: Shareholders are asked to approve a special resolution for the continuation of Mr. Ashok Kumar Ramawat’s directorship as a Non-Executive Independent Director upon attaining the age of 75 years on September 27, 2027, in compliance with Regulation 17(1A) of SEBI Listing Regulations.
• Related Party Transactions (RPT): An ordinary resolution seeks approval for material related party transactions with Cyano Pharma Private Limited (CPPL) for an aggregate value of up to ₹20 crore during FY27 and until the 42nd AGM.

Related Party Transaction Details

The proposed transactions with CPPL involve the purchase and sale of goods, job work services, and other resource transfers in the ordinary course of business. The Audit Committee approved the proposal, noting that the aggregate value exceeds the materiality threshold of 10% of the company’s annual consolidated turnover for FY26.

Mr. Ketan Shah (Chairman & Managing Director) and Mr. Smitesh Shah are shareholders in CPPL, establishing the related party relationship under Section 2(76) of the Companies Act, 2013. The transactions are expected to leverage CPPL’s supply network to optimize marketing and distribution costs.

Voting and Participation Details

Members can participate via VC/OAVM using the CDSL electronic platform. Remote e-voting is facilitated for all resolutions. The cut-off date for voting rights is September 16, 2026. The remote e-voting period runs from September 20, 2026, at 9:00 am to September 22, 2026, at 5:00 pm.

The Board approved the notice of the AGM on August 11, 2026. Ms. Darshika Wankhede, a Practicing Company Secretary, has been appointed as the Scrutinizer for the meeting. Results of the resolutions will be announced within two working days of the conclusion of the AGM.

Physical copies of the annual report are not being dispatched. Electronic copies have been sent to registered email addresses, while web-link letters are being sent to those without registered emails. Members holding shares in physical form are advised to update their KYC details with the Registrar and Share Transfer Agent, Ankit Consultancy Private Limited.

Regulatory Compliance

The meeting adheres to the Companies Act, 2013, and relevant circulars from the Ministry of Corporate Affairs (MCA) and SEBI. Apoorv Jain, Company Secretary and Compliance Officer, signed the disclosure dated August 11, 2026. The company reminded shareholders of the SEBI circular allowing the transfer and dematerialization of physical securities lodged before April 1, 2019, within the specified window ending February 4, 2027.